−0.77USD
−36.701MUSD
48.166M
About Cel-Sci Corporation
Sector
Industry
CEO
Geert R. Kersten
Website
Headquarters
Vienna
Founded
1983
ISIN
US1508376076
CEL-SCI Corp. is a biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.
CVM1Y
RSI is trending down.
MFI is trending down.
-Both have reached a top.
5Y
RSI is trending up.
MFI is trending up.
-Both have bottomed.
ALL
RSI is reaching a bottom.
MFI is trending down.
There is a gap around $0.80 and $1.
Prediction: I think we will continue falling near the $0.80 and $1 rang
CVM; Trend Analysis with ASCO reviewDisclaimer
I am very invested in CVM, for a multitude of reasons, first as a scientist, second as an investor, third as my ego. I believe their recent clinical trial results are phenomenal, and illustrate it's potential as the pre-treatment for cancer in immuno-competent patients with appropriate
CVM BullishPrice tested 4 fibonacci levels to close just under the .78 level. In addition the MACD just crossed on the daily.
Looks like $12.21 may act as resistance, in which case we may see a retracement to the $11.80-$11.22 level.
Target: $13.01 short term. $14.26-$16.71 possible if it starts to squeez.
CVM and Multikine; Rating and Confidence ReaffirmedDisclaimer
I am long $CVM to the tune of X0,000 shares (and growing). I genuinely believe, as a scientist, biochemist, and analyst, in Cel-Sci Corporation's Multikine. This article serves as the thesis that $CVM deserves that I have given to other stocks. As always buy shares, options are dangerous
Nice Long for CVM**SMALL ACCOUNT FRIENDLY PLAY**
Peep this insane chart!
**CVM**
Long above $12.50
Short below $11.22
$SPY $CVM
CVM; Breakout from bear pennant, prime for liftoffDisclaimer
General disclaimer here.
Short but sweet, we have sustained breakout from the bear pennant, we have a dwindling short pool (460k as of today borrowable from Fidelity, down from ~600k on Monday).
Less kick in the shorts, and they have until the 20th of this month to sustain the price c
CVM; Possible break of pennant into Gamma SqueezeDisclaimer
Not financial advice, blah blah blah.
Looking towards the end of current pennant into a gamma squeeze...
Options for 8/20 look like a massive gamma at 10 possible, with another big jump at 12.5 and 15. We could see a massive impulse up with intense gamma pressure from ~1.2 million shar
CVM; An Open Letter for a Large InvestorThis is an open letter to all large institutional investors with significant biotechnology/pharmaceutical experience.
The Company
Cel Sci Corp is a small, Immunology based biotech with a small pipeline outside of Multikine.
41 million shares outstanding with only State Street, BlackRock and Vangu
CVM; A brief breakdown and review of the crazy weekDisclaimer
Not financial advice, I literally wrote that gold is worthless if everyone just decides it to be so.
However, I put some effort into showing what I see what I look at the action. Everything is in the picture. TradingView fix your shit so I could have done this better.
Never think the
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
